AMLX
Price
$13.82
Change
-$0.00 (-0.00%)
Updated
Sep 26, 12:57 PM (EDT)
Capitalization
1.47B
41 days until earnings call
OCUL
Price
$12.70
Change
+$0.45 (+3.68%)
Updated
Sep 26, 01:20 PM (EDT)
Capitalization
2.13B
45 days until earnings call
Interact to see
Advertisement

AMLX vs OCUL

Header iconAMLX vs OCUL Comparison
Open Charts AMLX vs OCULBanner chart's image
Amylyx Pharmaceuticals
Price$13.82
Change-$0.00 (-0.00%)
Volume$800
Capitalization1.47B
Ocular Therapeutix
Price$12.70
Change+$0.45 (+3.68%)
Volume$100
Capitalization2.13B
AMLX vs OCUL Comparison Chart in %
Loading...
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
AMLX vs. OCUL commentary
Sep 26, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AMLX is a Buy and OCUL is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 26, 2025
Stock price -- (AMLX: $13.82 vs. OCUL: $12.24)
Brand notoriety: AMLX and OCUL are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: AMLX: 98% vs. OCUL: 109%
Market capitalization -- AMLX: $1.47B vs. OCUL: $2.13B
AMLX [@Biotechnology] is valued at $1.47B. OCUL’s [@Biotechnology] market capitalization is $2.13B. The market cap for tickers in the [@Biotechnology] industry ranges from $97.91B to $0. The average market capitalization across the [@Biotechnology] industry is $1.9B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

AMLX’s FA Score shows that 0 FA rating(s) are green whileOCUL’s FA Score has 0 green FA rating(s).

  • AMLX’s FA Score: 0 green, 5 red.
  • OCUL’s FA Score: 0 green, 5 red.
According to our system of comparison, both AMLX and OCUL are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

AMLX’s TA Score shows that 4 TA indicator(s) are bullish while OCUL’s TA Score has 3 bullish TA indicator(s).

  • AMLX’s TA Score: 4 bullish, 4 bearish.
  • OCUL’s TA Score: 3 bullish, 6 bearish.
According to our system of comparison, AMLX is a better buy in the short-term than OCUL.

Price Growth

AMLX (@Biotechnology) experienced а +4.30% price change this week, while OCUL (@Biotechnology) price change was -3.70% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +1.01%. For the same industry, the average monthly price growth was +9.06%, and the average quarterly price growth was +48.80%.

Reported Earning Dates

AMLX is expected to report earnings on Nov 06, 2025.

OCUL is expected to report earnings on Nov 10, 2025.

Industries' Descriptions

@Biotechnology (+1.01% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
OCUL($2.13B) has a higher market cap than AMLX($1.47B). AMLX YTD gains are higher at: 265.608 vs. OCUL (43.326). AMLX (-196.3M) and OCUL (-200.5M) have comparable annual earnings (EBITDA) . OCUL has more cash in the bank: 391M vs. AMLX (181M). AMLX has less debt than OCUL: AMLX (5.96M) vs OCUL (76.9M). OCUL has higher revenues than AMLX: OCUL (56.7M) vs AMLX (-249K).
AMLXOCULAMLX / OCUL
Capitalization1.47B2.13B69%
EBITDA-196.3M-200.5M98%
Gain YTD265.60843.326613%
P/E Ratio2.69N/A-
Revenue-249K56.7M-0%
Total Cash181M391M46%
Total Debt5.96M76.9M8%
FUNDAMENTALS RATINGS
OCUL: Fundamental Ratings
OCUL
OUTLOOK RATING
1..100
83
VALUATION
overvalued / fair valued / undervalued
1..100
53
Fair valued
PROFIT vs RISK RATING
1..100
85
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
40
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
75

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
AMLXOCUL
RSI
ODDS (%)
Bearish Trend 1 day ago
83%
Bearish Trend 1 day ago
71%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
80%
Bullish Trend 1 day ago
78%
Momentum
ODDS (%)
Bullish Trend 4 days ago
83%
Bearish Trend 1 day ago
79%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bearish Trend 1 day ago
83%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
81%
Bearish Trend 1 day ago
85%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
85%
Bullish Trend 1 day ago
88%
Advances
ODDS (%)
Bullish Trend 3 days ago
78%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 29 days ago
82%
Bearish Trend 10 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
83%
Aroon
ODDS (%)
Bullish Trend 1 day ago
88%
Bullish Trend 1 day ago
86%
View a ticker or compare two or three
Interact to see
Advertisement
AMLX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
OCUL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
AIIEX24.01N/A
N/A
Invesco EQV International Equity A
PRITX22.86N/A
N/A
T. Rowe Price International Stock
VCGAX36.22N/A
N/A
VALIC Company I Systematic Core Fund
ZSCCX32.89N/A
N/A
Zacks Small-Cap Core Inv
PVCMX12.64N/A
N/A
Palm Valley Capital Investor

AMLX and

Correlation & Price change

A.I.dvisor indicates that over the last year, AMLX has been closely correlated with XOMAO. These tickers have moved in lockstep 68% of the time. This A.I.-generated data suggests there is a high statistical probability that if AMLX jumps, then XOMAO could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AMLX
1D Price
Change %
AMLX100%
-0.43%
XOMAO - AMLX
68%
Closely correlated
-0.41%
XOMAP - AMLX
51%
Loosely correlated
-1.44%
LRMR - AMLX
46%
Loosely correlated
-4.71%
OCUL - AMLX
45%
Loosely correlated
-2.55%
RGNX - AMLX
45%
Loosely correlated
-1.89%
More

OCUL and

Correlation & Price change

A.I.dvisor indicates that over the last year, OCUL has been loosely correlated with EYPT. These tickers have moved in lockstep 65% of the time. This A.I.-generated data suggests there is some statistical probability that if OCUL jumps, then EYPT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To OCUL
1D Price
Change %
OCUL100%
-2.55%
EYPT - OCUL
65%
Loosely correlated
-6.32%
IDYA - OCUL
56%
Loosely correlated
+0.08%
CRNX - OCUL
55%
Loosely correlated
+2.02%
NRIX - OCUL
55%
Loosely correlated
-4.25%
DNLI - OCUL
54%
Loosely correlated
-0.37%
More